We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Inhibiting miRNA as a Foundation for New Gene Therapies?

News   Jul 29, 2019 | Original story from the Toyko Medical and Dental University

 
Inhibiting miRNA as a Foundation for New Gene Therapies?

This image illustrates the molecular mechanism how double-stranded HDO-antimiR silences the targeted microRNA within cells in comparison with the original single-stranded antimiR. These findings provide new insights into the biology of miRNA silencing and support the potential of this new class of molecules for use in treating miRNA-related diseases, such as cancer and cardiovascular disease. "HDO-antimiR appears to have different mechanisms of action compared with the parent antimiR," states first-author Yoshioka. "Thus, given its heightened intracellular miRNA-silencing potency, HDO-antimiR and the techniques that we used to construct it represent a new direction for miRNA regulation research." Credit: Department of Neurology and Neurological Science, TMDU.

 
 
 

RELATED ARTICLES

Freeze! Scientists Snap Artificial Proteins With Atomic Precision

News

Scientists at the U.S. Department of Energy's Lawrence Berkeley National Laboratory (Berkeley Lab) have adapted a technique that enlists the power of electrons to visualize a soft material's atomic structure while keeping it intact.

READ MORE

“Junk DNA” Affects Inherited Risk of Cancer

News

According to a new study, someone's risk of developing cancer is affected by genetic variations in regions of DNA that don’t code for proteins, previously dismissed as "junk DNA".

READ MORE

Revealing How Individual Cancer Cells React to Drugs

News

A new technique overcomes several limitations of typical high-throughput chemical screens conducted on cell samples. The new screening strategy combines improvements in labeling cell nuclei with advances in profiling what genes are expressed in each of millions of cells.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE